Pharming Group (PHAR)
8.35
+0.49
(+6.23%)
USD |
NASDAQ |
Jun 28, 16:00
8.125
-0.22
(-2.69%)
After-Hours: 20:00
Pharming Group Gross Profit (Quarterly): 47.20M for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 47.20M |
December 31, 2023 | 74.10M |
September 30, 2023 | 58.37M |
June 30, 2023 | 49.17M |
March 31, 2023 | 38.47M |
December 31, 2022 | 48.35M |
September 30, 2022 | 51.86M |
June 30, 2022 | 46.12M |
March 31, 2022 | 41.74M |
December 31, 2021 | 47.13M |
September 30, 2021 | 46.85M |
June 30, 2021 | 45.03M |
March 31, 2021 | 38.72M |
December 31, 2020 | 47.73M |
September 30, 2020 | 52.36M |
June 30, 2020 | 40.13M |
March 31, 2020 | 48.42M |
December 31, 2019 | 48.30M |
September 30, 2019 | 41.00M |
June 30, 2019 | 42.68M |
March 31, 2019 | 33.47M |
December 31, 2018 | 33.41M |
September 30, 2018 | 38.00M |
June 30, 2018 | 27.63M |
March 31, 2018 | 30.16M |
Date | Value |
---|---|
December 31, 2017 | 35.28M |
September 30, 2017 | 26.44M |
June 30, 2017 | 16.17M |
March 31, 2017 | 14.71M |
December 31, 2016 | 5.644M |
September 30, 2016 | 2.487M |
June 30, 2016 | 1.873M |
March 31, 2016 | 1.765M |
December 31, 2015 | 1.244M |
September 30, 2015 | 2.112M |
June 30, 2015 | 2.392M |
March 31, 2015 | 0.8425M |
December 31, 2014 | 20.10M |
September 30, 2014 | 0.4891M |
June 30, 2014 | 0.7304M |
March 31, 2014 | 0.2778M |
December 31, 2013 | 0.4287M |
September 30, 2013 | 1.105M |
June 30, 2013 | 5.762M |
March 31, 2013 | 0.6198M |
December 31, 2012 | 9.627M |
September 30, 2012 | 0.3676M |
June 30, 2012 | -2.247M |
March 31, 2012 | 0.6457M |
December 31, 2011 | -0.4967M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
38.47M
Minimum
Mar 2023
74.10M
Maximum
Dec 2023
47.69M
Average
47.16M
Median
Gross Profit (Quarterly) Benchmarks
uniQure NV | -0.741M |
ProQR Therapeutics NV | -- |
Merus NV | -- |
argenx SE | 357.82M |
Pharvaris NV | -- |